Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Rebound Orthopedics and Neurosurgery | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of the study is to determine the survivorship rate of robotically guided isolated patellofemoral implants at 2, 5 and 10 year postoperative.
The purpose of the study is to determine the survivorship rate of robotically guided isolated patellofemoral implants at 2, 5 and 10 year postoperative.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patellofemoral Knee Arthroplasty | Patient who have received a robotically guided isolated patellofemoral implant. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Robotically guided patellofemoral UKA isolated patellofemoral implants | Device | A robot guided isolated patellofemoral unicompartmental knee arthroplasty procedures to replace only the patellofemoral component of the knee. |
| Measure | Description | Time Frame |
|---|---|---|
| 10 year survivorship of robotically guided isolated patellofemoral implants. | 10 year survivorship of robotically guided isolated patellofemoral implants at 2,5, and 10 year follow up. | 10 years after surgery |
| Measure | Description | Time Frame |
|---|---|---|
| 2 year survivorship of robotically guided isolated patellofemoral implants. | The survivorship rate of robotically guided isolated patellofemoral implants at 2,5, and 10 year. | 2 years after surgery |
| 5 year survivorship of robotically guided isolated patellofemoral implants. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients who underwent a primary robotically guided UKA and received an isolated patellofemoral implant.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Thomas Coon, MD | St. Helena Hospital Coon Joint Replacement | Study Director |
| Todd Borus, MD | Rebound Orthopedics and Neurosurgery | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| St. Helena Hospital Coon Joint Replacement Institute | St. Helena | California | 94574 | United States | ||
Not provided
| ID | Term |
|---|---|
| D010003 | Osteoarthritis |
| ID | Term |
|---|---|
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
The survivorship rate of robotically guided isolated patellofemoral implants at 2,5, and 10 years post operative. |
| 5 years after surgery |
| Rebound Orthopedics and Neurosurgery |
| Vancouver |
| Washington |
| 98686 |
| United States |